<DOC>
	<DOCNO>NCT00626067</DOCNO>
	<brief_summary>The primary objective study determine opinion patient give Travatan Compliance Monitoring Dispenser use dispense Travatan glaucoma drop .</brief_summary>
	<brief_title>Study Patient Use Perception Travatan Dosing Aid</brief_title>
	<detailed_description>Patients enrol study use new Travatan compliance monitor dispenser 6 week . Patients informed , , patient ' compliance monitor device . Patients randomly assign one three group ( proportionally 2/2/1 ratio ) : 1 . Fully functional Travatan compliance monitor 2 . Travatan compliance monitor LCD display alarm disable , compliance monitoring intact 3 . Travatan compliance monitor LCD display , alarm compliance monitor disable . At end study , patient fill questionnaire assess 1 . Patient opinion regard device : ease use new device ; preference v Travatan use without device , etc 2. patient 's belief whether compliance monitor Rates adherence compare across group regard patient ' report belief whether monitor . The design study allow clinician ethically monitor compliance patient believe monitor . The use monitoring device without function display alarm lead patient believe monitored . As patient tell outset may may monitor , ethically acceptable design . However , collect data allow preliminary assessment impact patient ' belief whether monitor actual compliance , hence additional potential value device .</detailed_description>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Open angle glaucoma ocular hypertension Presently use Travatan eye drop Allergy prostaglandin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Travatan Dosing Aid</keyword>
	<keyword>compliance monitoring dispenser</keyword>
</DOC>